Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ovarian Serous Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02953457
What this trial is testing

Olaparib, Durvalumab, and Tremelimumab in Treating Patients With Recurrent or Refractory Ovarian, Fallopian Tube or Primary Peritoneal Cancer With BRCA1 or BRCA2 Mutation

Who this might be right for
BRCA1 Gene MutationBRCA2 Gene MutationOvarian Serous Adenocarcinoma+3 more
Roswell Park Cancer Institute 40
Not applicableUnknownNCT05537844
What this trial is testing

Longitudinal Sample Collection to Investigate Adaptation and Evolution of Ovarian High-grade Serous Carcinoma

Who this might be right for
Ovarian CancerHigh Grade Serous CarcinomaCarcinosarcoma, Ovarian+4 more
Liz-Anne Lewsley 250
Early research (Phase 1)Study completedNCT03552471
What this trial is testing

Mirvetuximab Soravtansine and Rucaparib Camsylate in Treating Participants With Recurrent Endometrial, Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Who this might be right for
BRCA1 Gene MutationBRCA2 Gene MutationFolate Receptor Alpha Positive+7 more
Ohio State University Comprehensive Cancer Center 25
Early research (Phase 1)Study completedNCT02307240
What this trial is testing

Open Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of CUDC-907 in Subjects With Advanced/Relapsed Solid Tumors

Who this might be right for
Triple-Negative Breast CancerHigh-grade Serous Ovarian CancerSolid Tumors+1 more
Curis, Inc. 43
Large-scale testing (Phase 3)Looking for participantsNCT04575935
What this trial is testing

Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial

Who this might be right for
Advanced Ovarian CarcinomaFallopian Tube Clear Cell AdenocarcinomaFallopian Tube Endometrioid Tumor+22 more
M.D. Anderson Cancer Center 580
Not applicableActive Not RecruitingNCT01608074
What this trial is testing

Radical Fimbriectomy for Young BRCA Mutation Carriers

Who this might be right for
BRCA1 MutationBRCA2 MutationHereditary Breast and Ovarian Cancer
Centre Oscar Lambret 123
Not applicableWithdrawnNCT04826029
What this trial is testing

Impact of Systematic Imaging for Follow up of Patients With Ovarian, Fallopian Tube or Primary Peritoneum Cancer

Who this might be right for
Advanced Stage Serous Epithelial Cancer of the OvaryAdvanced Stage Cancer of TubesAdvanced Stage Cancer of Peritoneum
Assistance Publique - Hôpitaux de Paris
Not applicableStudy completedNCT03593681
What this trial is testing

Compare Fallopian Tube Cells Collected by Cytuity With Removed Ovarian/Tubal Tissue to Determine Presence of Malignancy

Who this might be right for
Fallopian Tube CancerOvarian CancerOvarian Neoplasms+8 more
Boston Scientific Corporation 150
Large-scale testing (Phase 3)Looking for participantsNCT05601700
What this trial is testing

Letrozole for Estrogen/Progesterone Receptor Positive Low-grade Serous Epithelial Ovarian Cancer (LEPRE Trial)

Who this might be right for
Carcinoma, Ovarian EpithelialLow Grade Serous Adenocarcinoma of Ovary
Ente Ospedaliero Ospedali Galliera 132
Testing effectiveness (Phase 2)Looking for participantsNCT05080556
What this trial is testing

Adaptive ChemoTherapy for Ovarian Cancer in Patients With Replased Platinum-sensitive High Grade Serous or High Grade Endometrioid Ovarian Cancer

Who this might be right for
Ovarian CancerRelapsed Ovarian CancerFallopian Tube Cancer+4 more
University College, London 80
Testing effectiveness (Phase 2)Study completedNCT00520013
What this trial is testing

Avastin +/- Erlotinib Consolidation Chemotherapy After Carboplatin, Paclitaxel, and Avastin (CTA) Induction Therapy for Advanced Ovarian, Fallopian Tube, Primary Peritoneal Cancer & Papillary Serous or Clear Cell Mullerian Tumors

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer+2 more
Dana-Farber Cancer Institute 60
Early research (Phase 1)Study completedNCT01652794
What this trial is testing

Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer

Who this might be right for
Leydig Cell TumorOvarian SarcomaOvarian Stromal Cancer+10 more
Case Comprehensive Cancer Center 12
Early research (Phase 1)Study completedNCT00066651
What this trial is testing

Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors

Who this might be right for
Cervical CancerFallopian Tube CancerHead and Neck Cancer+5 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Ended earlyNCT04718675
What this trial is testing

KB-0742 in Participants With Relapsed or Refractory Solid Tumors Including Platinum Resistant High Grade Serous Ovarian Cancer (HGSOC)

Who this might be right for
Relapsed Solid TumorsRefractory Solid TumorsNon-Hodgkin Lymphoma+2 more
Kronos Bio 135
Testing effectiveness (Phase 2)Looking for participantsNCT06618235
What this trial is testing

Trial of THEO-260 in Ovarian Cancer Patients

Who this might be right for
Ovarian Cancer
Theolytics Limited 44
Early research (Phase 1)Looking for participantsNCT07690189
What this trial is testing

Study of NTB-928 in R/R OC

Who this might be right for
Relapsed/Refractory Ovarian Carcinoma
TeneoSeven, Inc. 90
Testing effectiveness (Phase 2)Looking for participantsNCT07617753
What this trial is testing

Dual-Targeting CAR-NK Cells for Recurrent Ovarian Cancer (MSLN, FRα, MUC16) pt2

Who this might be right for
Epithelial Ovarian CancerPrimary Peritoneal CarcinomaFallopian Tube Carcinoma+1 more
Beijing Biotech 36
Large-scale testing (Phase 3)UnknownNCT00108745
What this trial is testing

Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube Cancer

Who this might be right for
Fallopian Tube Clear Cell AdenocarcinomaFallopian Tube Endometrioid AdenocarcinomaFallopian Tube Mucinous Adenocarcinoma+24 more
GOG Foundation 1,157
Not applicableStudy completedNCT04991051
What this trial is testing

Study to Determine the Prevalence of Homologous Recombination Deficiency Among Women With Newly Diagnosed, High-grade, Serous or Endometrioid Ovarian, Primary Peritoneal, and/or Fallopian Tube Cancer

Who this might be right for
Fallopian Tube Cancer
AstraZeneca 605
Not applicableLooking for participantsNCT06777082
What this trial is testing

Role of RPL8 Protein Alterations in High-grade Serous Ovarian Carcinoma

Who this might be right for
High Grade Serous Ovarian Cancer
IRCCS Azienda Ospedaliero-Universitaria di Bologna 150
Next Page